Levitra

Levitra
Name	Levitra

Levitra is a medication used to treat Erectile Dysfunction (ED) in men, developed by Bayer and marketed by GlaxoSmithKline and Bayer. It is a Phosphodiesterase Type 5 (PDE5) inhibitor, similar to Sildenafil (marketed as Viagra) and Tadalafil (marketed as Cialis), and is used to treat ED in men with Diabetes Mellitus, Prostate Cancer, and other conditions, as studied by researchers at Harvard University and Johns Hopkins University. Levitra has been prescribed to millions of men worldwide, including those treated at Mayo Clinic and Cleveland Clinic. The medication has undergone extensive clinical trials, including those conducted by Pfizer and AstraZeneca, to ensure its safety and efficacy.

Introduction

Levitra, also known as Vardenafil, is a potent and selective inhibitor of PDE5, an enzyme that breaks down Cyclic Guanosine Monophosphate (cGMP) in the Corpus Cavernosum of the Penis. This medication has been used to treat ED in men with various underlying conditions, including Hypertension, Hyperlipidemia, and Depression, as diagnosed by American Psychological Association and treated by National Institute of Mental Health. Researchers at Stanford University and University of California, Los Angeles have studied the effects of Levitra on men with ED, and the results have been published in Journal of Urology and European Urology. The medication has been compared to other PDE5 inhibitors, such as Sildenafil and Tadalafil, in terms of its efficacy and safety, as reported by Food and Drug Administration and European Medicines Agency.

Medical_Uses

Levitra is primarily used to treat ED in men, including those with underlying conditions such as Diabetes Mellitus, Prostate Cancer, and Spinal Cord Injury, as treated by National Institutes of Health and World Health Organization. It is also used to treat Pulmonary Arterial Hypertension (PAH) in adults, as diagnosed by American Heart Association and treated by Cleveland Clinic. The medication has been studied in clinical trials conducted by Bayer and GlaxoSmithKline, and the results have been published in New England Journal of Medicine and Journal of the American Medical Association. Levitra has been prescribed to men with ED caused by various factors, including Aging, Smoking, and Obesity, as reported by Centers for Disease Control and Prevention and World Health Organization.

Pharmacology

Levitra works by inhibiting the action of PDE5, an enzyme that breaks down cGMP in the Corpus Cavernosum of the Penis. This leads to an increase in cGMP levels, causing Smooth Muscle Relaxation and increased Blood Flow to the Penis, resulting in an Erection, as described by researchers at University of Oxford and University of Cambridge. The medication has a rapid onset of action, with effects lasting for several hours, as reported by European Urology and Journal of Urology. Levitra is metabolized by the Liver and excreted in the Urine, as studied by researchers at National Institute of Diabetes and Digestive and Kidney Diseases and University of California, San Francisco.

Side_Effects

Levitra can cause several side effects, including Headache, Flushing, and Dyspepsia, as reported by Food and Drug Administration and European Medicines Agency. The medication can also cause more serious side effects, such as Priapism and Vision Loss, as diagnosed by American Academy of Ophthalmology and treated by National Eye Institute. Researchers at Harvard University and Johns Hopkins University have studied the safety and efficacy of Levitra, and the results have been published in New England Journal of Medicine and Journal of the American Medical Association. The medication has been compared to other PDE5 inhibitors, such as Sildenafil and Tadalafil, in terms of its side effect profile, as reported by Centers for Disease Control and Prevention and World Health Organization.

History

Levitra was first approved by the Food and Drug Administration in 2003 for the treatment of ED in men, as reported by Bayer and GlaxoSmithKline. The medication was developed by Bayer and marketed by GlaxoSmithKline and Bayer, and has undergone extensive clinical trials, including those conducted by Pfizer and AstraZeneca. Researchers at Stanford University and University of California, Los Angeles have studied the effects of Levitra on men with ED, and the results have been published in Journal of Urology and European Urology. The medication has been prescribed to millions of men worldwide, including those treated at Mayo Clinic and Cleveland Clinic.

Mechanism_of_Action

Levitra works by inhibiting the action of PDE5, an enzyme that breaks down cGMP in the Corpus Cavernosum of the Penis. This leads to an increase in cGMP levels, causing Smooth Muscle Relaxation and increased Blood Flow to the Penis, resulting in an Erection, as described by researchers at University of Oxford and University of Cambridge. The medication has a rapid onset of action, with effects lasting for several hours, as reported by European Urology and Journal of Urology. Levitra is metabolized by the Liver and excreted in the Urine, as studied by researchers at National Institute of Diabetes and Digestive and Kidney Diseases and University of California, San Francisco. The medication has been compared to other PDE5 inhibitors, such as Sildenafil and Tadalafil, in terms of its mechanism of action, as reported by Food and Drug Administration and European Medicines Agency.

Category:Phosphodiesterase inhibitors